Rapid eye movements are significantly delayed in patients with glaucoma, even those in the early stages of the disease, research has found.
The findings, led by Dr. Neeru Gupta, an ophthalmologist at St. Michael's Hospital, may shed new light on why glaucoma patients are at increased risk for falls and car accidents. Glaucoma is the leading cause of irreversible blindness.
Rapid (or saccadic) eye movements are the quick, simultaneous movements of both eyes in the same direction. They are involved in a myriad of everyday activities, from reading to scanning the surrounding environment, be it a busy subway station, grocery store shelves or oncoming traffic.
Dr. Gupta and co-workers studied groups of people with and without glaucoma who wore a head-mounted device that measured the length of time it took their eyes to move from one point to another, how long it took their eyes to begin the movement, did they focus on an object right away or did their eyes overshoot the target.
"Most of us take that processing of information for granted," she said.
However, she found that people with glaucoma showed delayed eye movement reaction times by about 15 per cent, even if they were in the early stages of the disease.
The findings were published online in the journal Eye and Brain.
Dr. Gupta said the findings are significant because they suggest that approaches to measuring vision loss beyond eye charts or visual field tests that related to real world settings may provide important clues to how the disease affects the lives of glaucoma patients. Glaucoma is becoming more common as the population ages and is expected to affect 80 million people worldwide by 2020. About half of all cases remain undiagnosed.
Currently, glaucoma can be diagnosed only by using a light to examine the optic nerve. Eye charts will not catch glaucoma, because it begins with peripheral vision loss long before reaching central vision.
All treatments for glaucoma -- eye drops, laser surgery and conventional surgery -- are designed to reduce pressure in the eye and help slow or stabilize damage to optic nerve. No treatment can reverse the disease.
"Now that we know that eye movement reaction times are delayed in people with glaucoma, there is an opportunity to understand the effects of glaucoma on daily activities of living that most of us take for granted, such as walking up and down stairs, driving, navigating and reading. Dr. Gupta said. "Just as alcohol causes a delay in hitting the brakes, glaucoma slows the time it takes to move the eyes quickly in response to a visual cue."
In previous work, Dr. Gupta and colleagues have demonstrated that glaucoma is a neurodegenerative disease affecting major vision pathways in the brain. Dr. Gupta's current paper points to a new vision pathway in the brain that is affected in glaucoma. Ninety per cent of signals from the optic nerve travel to an area at the back of the brain called the lateral geniculate nucleus. But the brain signals for rapid eye movements appear to travel a different route through the area known as the superior colliculus. A previous smaller study by Lamirel and coworkers published in the Journal of Glaucomain 2012 also showed that saccades were impaired in four glaucoma patients with visual field loss.
St. Michael's Hospital: http://www.stmichaelshospital.com/
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
By dipping live specimens in a chemical concoction, scientists are able to keep them alive in the vacuum conditions normally required for field emission scanning electron microscopy.
Astra Zeneca announces a research programme to develop a generation of medicines to treat the genetic causes of many debilitating diseases.
When patients with Parkinson's disease received an injection described as an effective drug costing $1,500 per dose, their motor function improved significantly more than when they got one supposedly costing $100, scientists reported on Wednesday.
New research shows that teenagers' brains aren't fully insulated, so the signals travel slowly when they need to make decisions. Neuroscientist Frances Jensen, who wrote The Teenage Brain, explains.
Researchers would use cohort of 1 million Americans pooled from smaller studies to study disease-gene links, improve personalized medicine
Some people have non-human neighbors of the usual, inspiring kind: Bald eagles and bears, sea lions and salamanders, the sort of creatures found in nature documentaries intoned by deep-voiced narrators who plead on our planet's behalf. But I live in New York City. The star of this show, a charismatic megafauna of my own particular wilderness, is none other than the rat — and what science is teaching us may change how we think of this oft-reviled creature, and maybe even ourselves.
An Oregon company has developed a high-tech process for turning sewage into pure drinking water. Now it's asking the state for permission to give its recycled water to a group of home brewers.
Skull cap of Homo sapiens found in Israeli cave hints at time and place of cross-species mingling
Is there a conscious generosity in how ravens or bats share food, or monkeys or elephants save others, or is it simply the selfish instinct of group survival?
DNA research into early canine remains also raises clues about migration patterns of ancient humans